Journal of cellular cancer is a peer-reviewed, optional open access journal that publishes original research articles, review articles, and clinical studies related to all aspects of cancer.
Journal of cellular cancer editors do all they can to ensure timely processing of manuscripts with the resources available to them. If editors intend to publish a manuscript, they will attempt to do so in a timely manner and any planned delays will be negotiated with the authors. If a Journal of cellular cancer has no intention of proceeding with a manuscript, editors will endeavor to reject the manuscript as soon as possible to allow authors to submit to a different journal.
Journal of cellular cancer currently has an acceptance rate of 28%. The average time between submission and final decision is 60-90 days, but may be more.
Journal of cellular cancer is semiannual published issues, the new articles has just been accepted in the journal will be published online through recent article while complete Current Issue is published at 30 th of each June and December.
Updated May 5, 2015
Cells were treated with 20 nM everolimus or vehicle every 48 h for 17 days canadian pharmacy cialis 20mg
8bk1ic
rp9bqt
priligy amazon Treatments with HA DOX hydrogels containing 4 mg mL HA and 0
Performing chemical flow reactions in droplet environments offers a potential solution to several of these problems priligy over the counter usa
primidone and lorazepam both increase sedation how to get cytotec without prescription Metabolism of TRP is tightly balanced between the activity of serotonin 5 HT pathway and the KP
buying generic cytotec for sale The online pharmacy is not responsible for any damage, arising from the use of this information about the anti inflammatory drug Mobic